Ergonex
Pfizer adds another product to its PAH franchise
May 14, 2010Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra
Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
